Skip to main content
logo
iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.430
-0.040 (-2.72%)
Aug 21, 2026, 4:00 PM EDT - Market closed

iBio, Inc. Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
7112181058329
Market Cap Growth
375.77%-31.98%77.58%-82.21%-82.49%25.19%
Enterprise Value
-112312237258
Last Close Price
1.430.762.1112.20132.00755.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
236.8030.9480.87-30.57138.74
PB Ratio
0.640.830.850.670.913.03
P/TBV Ratio
0.941.541.141.020.983.06

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
-29.35137.12-19.52108.69

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
0.030.240.231.140.410.30
Net Debt / Equity Ratio
-0.93-0.34-0.440.86-0.12-0.59
Net Debt / EBITDA Ratio
2.560.280.60-0.470.272.25
Net Debt / FCF Ratio
3.270.330.50-0.360.171.84
Asset Turnover
0.010.020.01-0.020.02
Inventory Turnover
-----3.54
Quick Ratio
11.501.423.700.201.1314.66
Current Ratio
11.881.594.081.191.4815.74
Return on Equity (ROE)
-62.09%-101.52%-84.15%-74.33%-34.31%-28.11%
Return on Assets (ROA)
-34.50%-44.79%-29.73%-25.58%-15.07%-16.05%
Return on Capital Employed (ROCE)
-36.50%-108.90%-66.80%-150.70%-43.10%-22.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-38.86%-148.48%-136.88%-634.44%-87.34%-7.05%
FCF Yield
-31.20%-123.78%-103.12%-359.78%-77.80%-10.63%
Buyback Yield / Dilution
-688.29%-174.05%-525.98%-40.35%-11.45%-211.53%
SEC Filings: 10-K · 10-Q